Radiopharmaceuticals Market report give rising open doors in the market and the future effect of significant drivers and difficulties and, bolster leaders in settling on practical business choices. Radiopharmaceuticals are a group of pharmaceuticals drug which have radioactivity. It can be used as diagnostic and therapeutic agent. Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical area for diagnosis or therapy.
Pune, India -- (SBWIRE) -- 03/08/2018 -- Data Bridge Market Research offerings new industry report "Radiopharmaceuticals Market report" contemplates the worldwide Radiopharmaceuticals showcase top to bottom and gives a comprehensive investigation of the key development variables, market and volume patterns, key players and their projections for what's to come.
"Global Radiopharmaceuticals Market" is expected to reach USD 9.49 billion by 2024 from USD 4.87 billion in 2016, at a CAGR of 8.7% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Click Here for Free Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-radiopharmaceuticals-market
Data Bridge Market Research report provides an extensive analysis of current and future market status of the "Global Radiopharmaceuticals Market" for purchase this report mail us at sopan.gedam@databridgemarketresearch.com Or call on number +1-888-387-2818
Market Segmentation:
The global market is segmented based on type, procedural volumes, application, sources, end-user, and geography.
On the basis of type, the global radiopharmaceuticals market is sub-segmented into
- Diagnostic
- Therapeutic radiopharmaceuticals.
In 2017, diagnostic radiopharmaceuticals segment dominate the market and is expected to grow at the highest in the forecast period. This is due to the production of MO-99 in the U.S., FDA approvals of radiopharmaceuticals, initiatives of International Atomic Energy Agency (IAEA), new irradiation facility in Germany, installation of PET scanners in India, andgovernment investments in Rest of Asia-Pacific.
On the basis of procedural volumes, the global radiopharmaceuticals market is sub-segmented into
- Diagnostic procedure
- single-photon emission computed tomography (SPECT) radiopharmaceuticals
- positron emission tomography (PET) radiopharmaceuticals
- Therapeutic procedures
- beta emitters
- alpha emitters
- brachy therapy
On the basis of application, the global radiopharmaceuticals market is sub-segmented into
- diagnostic application
- single-photon emission computed tomography (SPECT) -
- positron emission tomography (PET)- oncology, cardiology, neurology and others
- therapeutic application
- thyroid,
- bone metastasis,
- lymphoma,
- endocrine tumours
- others
On the basis of sources, the global radiopharmaceuticals market is sub-segmented into
- nuclear reactors
- cyclotrons
On the basis of end user, the global radiopharmaceuticals market is sub-segmented into
- hospitals,
- ambulatory surgical centers,
- diagnostic centers,
- cancer research institutes and
- others
In 2017, hospital segment dominate the market with the highest market share due to accessibility of highly skilled medical practitioners in the radiology departments of hospitals.
Request for Table of Content of Full Report @ http://databridgemarketresearch.com/toc/?dbmr=global-radiopharmaceuticals-market
Major Players in Global Radiopharmaceuticals Market are included which give a brief analysis of following points:
- Market Overview
- Market Dynamics
- Drivers, Restraints, Opportunities and Challenges
- Market sizing and growth analysis
- Market forecasting to 2024
- Market Competitive Landscape
- Product Launches and Pipeline Analysis
- Value Chain Analysis
- Market Mergers, Acquisitions and Agreements
- Company Profiles
Top Challengers:
- Cardinal Health Inc.
-
- GE Healthcare
- Lantheus Medical Imaging Inc.
- Bayer AG
- Bracco Imaging SpA
- Eczacibasi-Monrol Nuclear Products
- Nordion Inc.
- Advanced Accelerator Applications S.A.
- IBA Molecular Imaging
- Actinium Pharmaceuticals Inc.,
- Among others.
Read more about Report Visit @ http://databridgemarketresearch.com/reports/global-radiopharmaceuticals-market/
Related Report
North America Digital Health Monitoring Market – Industry Trends and Forecast to 2024
North America Digital Health Monitoring Market By Product Type Devices (Blood Pressure Monitors, Blood Glucose Monitors, ECG, Oximeters, Peak Flow Monitors, Multi Parameter Monitors, Sleep Neap Monitors, Neurological Monitors, Others), Software (Healthcare Apps, Chronic Disease Apps, Personal Health Apps, Others), Services (Remote Monitoring, Consultancy Services, Treatment Services, Fitness and Wellness Services, Others), By Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2024
Report Access: http://databridgemarketresearch.com/reports/north-america-digital-health-monitoring-devices-market/
About Data Bridge Market Research
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com